DK2080516T3 - Anvendelse af isothiocyanatderivater som anti-myelom-midler - Google Patents

Anvendelse af isothiocyanatderivater som anti-myelom-midler

Info

Publication number
DK2080516T3
DK2080516T3 DK08100658.7T DK08100658T DK2080516T3 DK 2080516 T3 DK2080516 T3 DK 2080516T3 DK 08100658 T DK08100658 T DK 08100658T DK 2080516 T3 DK2080516 T3 DK 2080516T3
Authority
DK
Denmark
Prior art keywords
isothiocyanate derivatives
myeloma
myeloma agents
agents
isothiocyanate
Prior art date
Application number
DK08100658.7T
Other languages
English (en)
Inventor
Paolo Morazzoni
Carla Manzotti
Gabriele Fontana
Antonella Riva
Renato Iori
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK2080516T3 publication Critical patent/DK2080516T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK08100658.7T 2008-01-18 2008-01-18 Anvendelse af isothiocyanatderivater som anti-myelom-midler DK2080516T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100658A EP2080516B1 (en) 2008-01-18 2008-01-18 Use of isothiocyanate derivatives as anti-myeloma agents

Publications (1)

Publication Number Publication Date
DK2080516T3 true DK2080516T3 (da) 2011-07-11

Family

ID=39247811

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08100658.7T DK2080516T3 (da) 2008-01-18 2008-01-18 Anvendelse af isothiocyanatderivater som anti-myelom-midler

Country Status (17)

Country Link
US (1) US8772251B2 (da)
EP (1) EP2080516B1 (da)
JP (1) JP5386507B2 (da)
KR (1) KR101523042B1 (da)
CN (1) CN101918006B (da)
AT (1) ATE511845T1 (da)
AU (1) AU2008347390B2 (da)
CA (1) CA2712258C (da)
DK (1) DK2080516T3 (da)
ES (1) ES2363385T3 (da)
HR (1) HRP20110451T1 (da)
IL (1) IL207011A (da)
PL (1) PL2080516T3 (da)
PT (1) PT2080516E (da)
RU (1) RU2480217C2 (da)
SI (1) SI2080516T1 (da)
WO (1) WO2009089889A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
WO2013041204A1 (de) 2011-09-23 2013-03-28 2LUTION GmbH Neue isocyanat- und isothiocyanat-verbindungen zur behandlung von krebs
WO2014018874A1 (en) 2012-07-26 2014-01-30 The William M. Yarbrough Foundation Method for treating skin cancer
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
CN103262850B (zh) * 2013-01-16 2014-06-11 长沙理工大学 一种石蒜生长促进剂及其使用方法
EP2974726A4 (en) * 2013-03-14 2017-01-04 Tiacen Ltd Agent for the prophylaxis and/or treatment of neoplastic diseases
US20160243176A1 (en) * 2013-11-01 2016-08-25 Rutgers, The State University Of New Jersey Extracts from plants of the moringaceae family and methods of making
EP3078371A1 (en) * 2015-04-10 2016-10-12 INDENA S.p.A. Use of isothiocyanate derivatives as modulators of peripheral and neuropathic pain
CN107857781A (zh) * 2017-11-16 2018-03-30 云南农业大学 一种从辣木籽中制备4‑α‑L‑鼠李糖基‑异硫氰酸苄酯的方法
EP4534542A1 (en) * 2023-10-02 2025-04-09 Universidad de Sevilla Thiosugar based isothiocyanates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5132865B2 (ja) * 2000-08-21 2013-01-30 ジェド ダブリュ． ファーヒー イソチオシアネートを用いたヘリコバクターの治療方法
US6988664B1 (en) * 2004-09-30 2006-01-24 Symbol Technologies, Inc. Removable cover for an electronic device
WO2006065736A2 (en) * 2004-12-14 2006-06-22 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolsate-containing plants

Also Published As

Publication number Publication date
SI2080516T1 (sl) 2011-09-30
CN101918006A (zh) 2010-12-15
CA2712258C (en) 2013-12-10
ES2363385T3 (es) 2011-08-02
EP2080516B1 (en) 2011-06-08
CN101918006B (zh) 2012-11-21
KR101523042B1 (ko) 2015-05-26
JP2011509955A (ja) 2011-03-31
WO2009089889A1 (en) 2009-07-23
PT2080516E (pt) 2011-07-01
JP5386507B2 (ja) 2014-01-15
EP2080516A1 (en) 2009-07-22
AU2008347390B2 (en) 2014-03-13
US20110053870A1 (en) 2011-03-03
KR20100102660A (ko) 2010-09-24
US8772251B2 (en) 2014-07-08
IL207011A (en) 2014-04-30
ATE511845T1 (de) 2011-06-15
CA2712258A1 (en) 2009-07-23
AU2008347390A1 (en) 2009-07-23
PL2080516T3 (pl) 2011-12-30
IL207011A0 (en) 2010-12-30
HRP20110451T1 (hr) 2011-07-31
RU2010129238A (ru) 2012-01-20
RU2480217C2 (ru) 2013-04-27

Similar Documents

Publication Publication Date Title
IL207011A0 (en) Use of isothiocyanate derivatives as anti-myeloma agents
CY1124855T1 (el) 2-(μορφολιν-4-υλ)-1,7-ναφθυριδινες
LTC2137143I2 (lt) Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
DK2315756T3 (da) 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DOP2010000326A (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
NO20090313L (no) Derivater og analoger av N-etylkinoloner og N-etylazakinoloner
CR20150085A (es) Nuevas 6-aminoacido-heteroarildihidropirmidindas para el tratamiento y profilaxis de la infección del virus de la hepatitis b
AR078766A1 (es) Formas solidas de n-(4-(7-azabiciclo(2.2.1) heptan-7-il)-2-( trifluorometil) fenil)-4-oxo-5-(trifluorometil)-1,4- dihidroquinolina-3-carboxamida
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
HN2008000311A (es) Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
DK2177224T3 (da) Forbindelse til forebyggelse og behandling af lidelser, som involverer modulation af RyR-receptorerne
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK3689346T3 (da) 3,6-disubstitueret xanthyliumsalte til behandling af tauopati
DK2041128T3 (da) Substituerede gamma-lactamer som terapeutiske agenser
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2148667T3 (da) Anvendelse af cyclohexanhexolderivater til behandling af øjensygdomme
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK1965787T3 (da) Behandling af xerostomi med en svovlindeholdende antioxidant
DK2069353T3 (da) Polycykliske midler til behandling af infektioner med respiratorisk syncytialvirus
DK2114406T3 (da) Thioxanthen-derivater som eneste anti-infektive middel til anvendelse i behandlingen af infektionssygdomme